Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 9, 2009, Pages 925-932

  Chen, Dan Dan ^a   Dong, Yu Gang ^a   Liu, Dan ^a   He, Jian Gui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hypertension; Hypertrophy; Mitochondria; Mitogen activated protein kinases; Nuclear factor

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CATALASE; EPIGALLOCATECHIN GALLATE; GELATINASE B; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HISTOPATHOLOGY; HYPERTENSION; HYPOTHESIS; MALE; MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; TRANSAORTIC ABDOMINAL AORTIC CONSTRICTION; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; ATRIAL NATRIURETIC FACTOR; CATALASE; CATECHIN; DISEASE MODELS, ANIMAL; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENZYME ACTIVATION; GLUTATHIONE PEROXIDASE; HEMODYNAMICS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MALONDIALDEHYDE; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOCHONDRIA, HEART; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP-1;

EID: 69949092173     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05173.x     Document Type: Article

References (26)

1. Seddon M, Looi YH, Shah AM. Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 2007 93 : 903 907.
2. Oudit GY, Penninger JM. Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc. Res. 2009 82 : 250 260.
3. Takai S, Matsushima-Nishiwaki R, Adachi S et al. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: Suppression of SAPK/JNK. Mediators Inflamm. 2008 2008 : 291808.
4. Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr. 2003 43 : 89 143.
5. Huo C, Wan SB, Lam WH et al. The challenge of developing green tea polyphenols as therapeutic agents. Inflammopharmacology 2008 16 : 248 252.
6. Dou QP, Landis-Piwowar KR, Chen D, Huo C, Wan SB, Chan TH. Green tea polyphenols as a natural tumour cell proteasome inhibitor. Inflammopharmacology 2008 16 : 208 212.
7. Chen D, Milacic V, Chen MS et al. Tea polyphenols, their biological effects and potential molecular targets. Histol. Histopathol. 2008 23 : 487 496.
8. Li HL, Huang Y, Zhang CN et al. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic. Biol. Med. 2006 40 : 1756 1775.
9. Priyadarshi S, Valentine B, Han C et al. Effect of green tea extract on cardiac hypertrophy following 5/6 nephrectomy in the rat. Kidney Int. 2003 63 : 1785 1790.
10. Zheng Y, Song HJ, Kim CH et al. Inhibitory effect of epigallocatechin 3-O-gallate on vascular smooth muscle cell hypertrophy induced by angiotensin II. J. Cardiovasc. Pharmacol. 2004 43 : 200 208.
11. Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD. PPAR (gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice. Hypertension 2004 43 : 661 666.
12. Madesh M, Benard O, Balasubramanian KA. Apoptotic process in the monkey small intestinal epithelium: 2. Possible role of oxidative stress. Free Radic. Biol. Med. 1999 26 : 431 438. (Pubitemid 29013475)
13. Megli FM, Sabatini K. Respiration state IV-generated ROS destroy the mitochondrial bilayer packing order in vitro. An EPR Study. FEBS Lett. 2003 550 : 185 189.
14. Suliman HB, Carraway MS, Welty-Wolf KE, Whorton AR, Piantadosi CA. Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1. J. Biol. Chem. 2003 278 : 41 510 18.
15. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 11 : 1475 1489.
16. Saba H, Munusamy S, Macmillan-Crow LA. Cold preservation mediated renal injury: Involvement of mitochondrial oxidative stress. Ren. Fail. 2008 30 : 125 133.
17. Li JM, Gall NP, Grieve DJ, Chen M, Shah AM. Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002 40 : 477 484.
18. Liang Q, Molkentin JD. Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: Dichotomy between cultured myocytes and animal models. J. Mol. Cell. Cardiol. 2003 35 : 1385 1394.
19. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 2005 115 : 500 508.
20. Sano M, Fukuda K, Sato T et al. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ. Res. 2001 89 : 661 669.
21. Takemoto Y, Yoshiyama M, Takeuchi K et al. Increased JNK, AP-1 and NF-kappa B DNA binding activities in isoproterenol-induced cardiac remodeling. J. Mol. Cell. Cardiol. 1999 31 : 2017 2030.
22. Moon SK, Cho GO, Jung SY et al. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: Role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 2003 301 : 1069 1078.
23. Wilson EM, Spinale FG. Myocardial remodelling and matrix metalloproteinases in heart failure: Turmoil within the interstitium. Ann. Med. 2001 33 : 623 634.
24. Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002 21 : 251 262.
25. Anan R, Nakagawa M, Miyata M et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995 91 : 955 961.
26. Melov S, Schneider JA, Day BJ et al. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998 18 : 159 163.